Numerate, Inc.

UEI: DYZZL3651LF3
CAGE: 4THP8
Primary NAICS: 541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration: Expired May 23, 2020

Company facts

Self-certified in SAM.gov: For Profit Organization
Entity structure: Corporate Entity (Not Tax Exempt)
Other NAICS codes in SAM.gov: 325411 Medicinal and Botanical Manufacturing

541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration date: Jul 16, 2007
Website: numerate.com
Founded: 2007
Employees: 11-50
Estimated annual revenue: $1M-$10M
Industry: Health Care

Pharmaceuticals, Biotechnology & Life Sciences

Biotechnology
SIC code: 87 Engineering & Management Services
Profiles: LinkedIn

X

Facebook

Crunchbase

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated Nov 1, 2020.

Contract awards

Award	Agency	Obligated	Awarded
Base period HDTRA110C0029	Defense Threat Reduction Agency	$4,903,991	Jun 30, 2010

Grant awards

Award	Agency	Obligated	Awarded
EZH2 inhibitors as endoprosthetic device coatings that induce osteogenesis and promote implant osseointegration R43AR073051	National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH)	$224,878	Sep 13, 2017
Peripherally restricted ??2/??-1 subunit ligands that modulate CAV channel gating as novel antiarrhythmic drugs R44HL139143	National Heart Lung and Blood Institute (NIH)	$0	Aug 1, 2017
Peripherally restricted ?2/?-1 subunit ligands that modulate CAV channel gating as novel antiarrhythmic drugs R43HL139143	National Heart Lung and Blood Institute (NIH)	$224,927	Aug 1, 2017
Drug engineering of transglutaminase 2 inhibitors R41DK081244	National Institutes of Health	$252,139	Feb 1, 2009

Quick answers

Is Numerate, Inc. registered in SAM.gov?

Numerate, Inc.'s SAM.gov registration expired on May 23, 2020.

What is Numerate, Inc.'s CAGE code?

Numerate, Inc.'s CAGE code is 4THP8, and its Unique Entity ID (UEI) is DYZZL3651LF3.

What is Numerate, Inc.'s most recent federal award?

Numerate, Inc.'s most recent federal grant award is EZH2 inhibitors as endoprosthetic device coatings that induce osteogenesis and promote implant osseointegration (R43AR073051), from National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH), on September 13, 2017.

On GovTribe

See Numerate, Inc.'s full federal record

Federal contract awards
Federal grant awards
Funding analysis by agency, NAICS and set-aside
Similar vendors

Try for free Login

Find teaming partners on GovTribe